Pragmatic study design may help increase minority participation in clinical trials, new data suggest

Pragmatic study designs may increase clinical trial participation among minority patients with multiples sclerosis (MS), according to researchers in the USA and UK.

Racial/ethnic minority groups are often underrepresented in randomized trials, the researchers noted. Pragmatic trials, such as the ongoing DELIVER-MS trial, have permissive entry requirements that may improve minority participation.